Literature DB >> 8707073

Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.

N I McDougall1, B T Johnston, F Kee, J S Collins, R J McFarland, A H Love.   

Abstract

BACKGROUND: Although oesophagitis is the most common diagnosis made at upper gastrointestinal endoscopy, data on the longterm outcome of affected patients are sparse. AIMS: This study assessed the level of reflux symptoms, quality of life, drug consumption, and complications in patients at least 10 years after diagnosis of oesophagitis at one centre. PATIENTS: One hundred and fifty two patients with typical reflux symptoms and a first time diagnosis by endoscopy of grade I-III oesophagitis between 1981 and 1984, were followed up using a postal questionnaire and telephone interview.
RESULTS: Eighteen of 152 patients had died, 33 failed to respond, and 101 replied (mean follow up 11 years, range 121-160 months). Over 70% of patients still had heartburn at least daily (32%) or weekly (19%) or required daily acid suppression treatment (20%). Two patients (2%) had developed oesophageal strictures and one had Barrett's oesophagus. Two of eight quality of life scores (physical function and social function) measured by the Short Form-36 were significantly lower than Northern Ireland population scores.
CONCLUSION: Nearly three quarters of patients previously diagnosed as having oesophagitis still had significant morbidity related to gastro-oesophageal reflux disease more than 10 years after diagnosis. Some quality of life scores were significantly lower than those of the general population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707073      PMCID: PMC1383100          DOI: 10.1136/gut.38.4.481

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

1.  Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.

Authors:  L Lundell; L Backman; P Ekström; L K Enander; S Falkmer; O Fausa; L Grimelius; N Havu; T Lind; H Lönroth
Journal:  Scand J Gastroenterol       Date:  1991-03       Impact factor: 2.423

2.  Esophageal symptoms, manometry, and histology before and after antireflux surgery: a long-term follow-up study.

Authors:  D L Brand; I R Eastwood; D Martin; W B Carter; C E Pope
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

3.  Nissen fundoplication. Results at 10 year follow-up.

Authors:  J B Negre; H T Markkula; O Keyrilainen; M Matikainen
Journal:  Am J Surg       Date:  1983-11       Impact factor: 2.565

4.  Heartburn and globus in apparently healthy people.

Authors:  W G Thompson; K W Heaton
Journal:  Can Med Assoc J       Date:  1982-01-01       Impact factor: 8.262

5.  Medical therapy for chronic reflux esophagitis. Long-term follow-up.

Authors:  D A Lieberman
Journal:  Arch Intern Med       Date:  1987-10

6.  Healing and relapse of reflux esophagitis during treatment with ranitidine.

Authors:  H R Koelz; R Birchler; A Bretholz; B Bron; Y Capitaine; G Delmore; H F Fehr; I Fumagalli; J Gehrig; J J Gonvers
Journal:  Gastroenterology       Date:  1986-11       Impact factor: 22.682

Review 7.  Epidemiology of reflux disease and reflux esophagitis.

Authors:  M Wienbeck; J Barnert
Journal:  Scand J Gastroenterol Suppl       Date:  1989

8.  Symptomatic gastroesophageal reflux: incidence and precipitating factors.

Authors:  O T Nebel; M F Fornes; D O Castell
Journal:  Am J Dig Dis       Date:  1976-11

9.  Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease.

Authors:  K E Johansson; P Ask; B Boeryd; S G Fransson; L Tibbling
Journal:  Scand J Gastroenterol       Date:  1986-09       Impact factor: 2.423

10.  Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients.

Authors:  T R DeMeester; L Bonavina; M Albertucci
Journal:  Ann Surg       Date:  1986-07       Impact factor: 12.969

View more
  38 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

Review 2.  Acid suppression in gastro-oesophageal reflux disease: Why? How? How much and when?

Authors:  M P Jones
Journal:  Postgrad Med J       Date:  2002-08       Impact factor: 2.401

Review 3.  Quality of life assessment in gastro-oesophageal reflux disease.

Authors:  E J Irvine
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

4.  Natural history of heartburn: a 10-year population-based study.

Authors:  Linda Bjork Olafsdottir; Hallgrimur Gudjonsson; Heidur Hrund Jonsdottir; Bjarni Thjodleifsson
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

5.  [1997 gastroenterology update--I].

Authors:  W Fischbach; S S Gro; J Schölmerich; C Ell; P Layer; W E Fleig; H Zirngibl
Journal:  Med Klin (Munich)       Date:  1998-02-15

6.  Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions--a debate: pro.

Authors:  Tomás Navarro-Rodriguez; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

7.  [Antireflux therapy--more than acid reduction?].

Authors:  T Frieling
Journal:  Internist (Berl)       Date:  2004-12       Impact factor: 0.743

8.  The epidemiology of gastroesophageal reflux disease: a survey on the prevalence and the associated factors in a random sample of the general population in the Northern part of Iran.

Authors:  Fariborz Mansour-Ghanaei; Farahnaz Joukar; Seyed Mehrbod Atshani; Sepideh Chagharvand; Fatemeh Souti
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

9.  Trends in gastroesophageal reflux disease as measured by the National Ambulatory Medical Care Survey.

Authors:  Frank K Friedenberg; Alexandra Hanlon; Vishwas Vanar; Dawit Nehemia; Jyothi Mekapati; Deborah B Nelson; Joel E Richter
Journal:  Dig Dis Sci       Date:  2009-10-15       Impact factor: 3.199

10.  Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study.

Authors:  David Epstein; Laura Bojke; Mark J Sculpher
Journal:  BMJ       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.